NCT00460551 2011-12-06Zalutumumab in Combination With Chemo-Radiation in a Certain Type of Lung CancerGenmabPhase 2 Terminated13 enrolled 7 charts
NCT01449357 2011-10-10Zalutumumab in Non-Small Cell Lung Cancer (NSCLC) Patients Refractory to Tyrosine Kinase InhibitorsGenmabPhase 2 Withdrawn